These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 22416874

  • 1. Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants.
    Marioni G, Agostini M, Bedin C, Blandamura S, Stellini E, Favero G, Lionello M, Giacomelli L, Burti S, D'Angelo E, Nitti D, Staffieri A, De Filippis C.
    Histopathology; 2012 Aug; 61(2):247-56. PubMed ID: 22416874
    [Abstract] [Full Text] [Related]

  • 2. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation.
    Pizem J, Cör A, Gale N.
    Histopathology; 2004 Aug; 45(2):180-6. PubMed ID: 15279637
    [Abstract] [Full Text] [Related]

  • 3. Expression and significance of hypoxia-inducible factor-1α and survivin in laryngeal carcinoma tissue and cells.
    Li DW, Zhou L, Jin B, Xie J, Dong P.
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):75-81. PubMed ID: 23087365
    [Abstract] [Full Text] [Related]

  • 4. [Expression of P53 protein in laryngeal carcinoma and its clinical significance].
    Wang D, Yi Z, Yang F.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995 Jan; 30(6):354-6. PubMed ID: 8762527
    [Abstract] [Full Text] [Related]

  • 5. High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma.
    Marioni G, Ottaviano G, Marchese-Ragona R, Giacomelli L, Bertolin A, Zanon D, Marino F, Staffieri A.
    Acta Otolaryngol; 2006 Feb; 126(2):197-203. PubMed ID: 16428200
    [Abstract] [Full Text] [Related]

  • 6. Relationship between anti-apoptotic proteins survivin and Bcl-2, and response to treatment in patients undergoing post-operative RT for laryngeal cancer: a pilot study.
    Marioni G, Staffieri A, Lionello M, Tealdo G, Staffieri C, Giacomelli L, Friso ML, Stramare R, Ottaviano G, Blandamura S.
    J Oral Pathol Med; 2013 Apr; 42(4):339-44. PubMed ID: 23126236
    [Abstract] [Full Text] [Related]

  • 7. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma.
    Shi Y, Gong HL, Zhou L, Tian J, Wang Y.
    ORL J Otorhinolaryngol Relat Spec; 2012 Apr; 74(2):78-85. PubMed ID: 22354323
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
    Chau GY, Lee AF, Tsay SH, Ke YR, Kao HL, Wong FH, Tsou AP, Chau YP.
    Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
    [Abstract] [Full Text] [Related]

  • 9. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
    Ikeguchi M, Kaibara N.
    Br J Cancer; 2002 Oct 07; 87(8):883-7. PubMed ID: 12373603
    [Abstract] [Full Text] [Related]

  • 10. [Correlation of EphA2 protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
    Liu Y, Zhang X, Qiu YZ, Huang DH, Zhou XJ, Tan PQ, Cai GM, Dai YZ, Yu CY, Xiao JY, Tian YQ.
    Zhonghua Zhong Liu Za Zhi; 2011 Mar 07; 33(3):197-201. PubMed ID: 21575519
    [Abstract] [Full Text] [Related]

  • 11. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, Bisen PS.
    Head Neck; 2009 Aug 07; 31(8):1039-48. PubMed ID: 19340865
    [Abstract] [Full Text] [Related]

  • 12. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S.
    Int J Oncol; 2005 Oct 07; 27(4):1151-7. PubMed ID: 16142334
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic significance of p53/bcl-2 co-expression in patients with laryngeal squamous cell carcinoma.
    Jäckel MC, Sellmann L, Dorudian MA, Youssef S, Füzesi L.
    Laryngoscope; 2000 Aug 07; 110(8):1339-45. PubMed ID: 10942137
    [Abstract] [Full Text] [Related]

  • 15. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma.
    Marioni G, Ottaviano G, Marchese-Ragona R, Fasanaro E, Tealdo G, Zanotti C, Randon B, Giacomelli L, Stellini E, Blandamura S.
    J Clin Pathol; 2017 Dec 07; 70(12):1033-1037. PubMed ID: 28446541
    [Abstract] [Full Text] [Related]

  • 16. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM, Luan XY, Lei DP, Ma XJ, Liu XX, Liu J, Pan XL.
    ORL J Otorhinolaryngol Relat Spec; 2008 Dec 07; 70(3):168-75. PubMed ID: 18391576
    [Abstract] [Full Text] [Related]

  • 17. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma.
    Huang Y, Chen X, Chen N, Nie L, Xu M, Zhou Q.
    J Clin Pathol; 2011 Nov 07; 64(11):953-9. PubMed ID: 21730264
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis.
    Liu WW, Zeng ZY, Wu QL, Hou JH, Chen YY.
    Otolaryngol Head Neck Surg; 2005 Mar 07; 132(3):395-400. PubMed ID: 15746850
    [Abstract] [Full Text] [Related]

  • 20. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L, Wang Y, Xiao M, Lin Y, Yu L.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct 07; 110(4):484-91. PubMed ID: 20868995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.